Company Directory / Medical Device

CeQur Simplicity logo

PrivateFor profitMedical DeviceHorw, Switzerland

CeQur Simplicity

CeQur Simplicity develops drug delivery devices.

Founded
2008
18 years ago
Staff
51-100
122 on LinkedIn
Followers
9k
on LinkedIn
Funding
$272M
as listed, USD

CeQur®, a medical device company dedicated to simplifying mealtime insulin delivery for individuals on multiple daily injections, manufactures CeQur Simplicity, a simple-to-use wearable insulin delivery device enabling discreet, convenient and injection-free bolus dosing. In June 2024, the company announced the FDA's recent 510(k) clearance of CeQur Simplicity for an extended wear duration from 3 to 4 days. One CeQur Simplicity 4-day wearable patch holds up to 200 units of rapid-acting insulin administered in… Read all

CeQur®, a medical device company dedicated to simplifying mealtime insulin delivery for individuals on multiple daily injections, manufactures CeQur Simplicity, a simple-to-use wearable insulin delivery device enabling discreet, convenient and injection-free bolus dosing. In June 2024, the company announced the FDA's recent 510(k) clearance of CeQur Simplicity for an extended wear duration from 3 to 4 days. One CeQur Simplicity 4-day wearable patch holds up to 200 units of rapid-acting insulin administered in two-unit increments and replaces, on average, twelve daily mealtime injections over four days. CeQur is headquartered in Horw, Switzerland. Please visit myceqursimplicity.com for more information.

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

51-100 people: larger than 75% of companies with a size listed. 122 people list it on LinkedIn.

Age

200819002026

18 years old.

Reach

Website ranked #3,300,350 in the world for traffic, about 4k visits a month. 8,623 followers on LinkedIn.

What it does

Health CareMedicalMedical DeviceMedical DeviceType 2 diabetesInsulin deliveryDrug DeliveryPumpsInsulin PatchType 1 diabetesglucose management

Funding, as listed

$272M raised in total

  • Rounds4
  • LatestSeries c, Apr 2021
  • Latest amountUSD 120,000,000
  • Investors12, 4 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersJames Peterson
Acquisitions made1

Every detail we hold

Everything the source datasets list about CeQur Simplicity, field by field. Contact details are held but never shown.

The company

Name
CeQur Simplicity
Type
For profit
Status
Private
Founded
2008
Founders
James Peterson
Industry
Medical Device
Categories
Health Care, Medical, Medical Device
Specialities
Medical Device, Type 2 diabetes, Insulin delivery, Drug Delivery, Pumps, Insulin Patch, Type 1 diabetes, glucose management

Where

City
Horw
Country
Switzerland
Markets
Europe, Middle East, and Africa (EMEA)

Size and reach

Staff band
51-100
People on LinkedIn
122
LinkedIn followers
8,623
Web traffic rank
#3,300,350
Monthly web visits
4,271

Funding, as listed

Total
$271,600,000 USD
Rounds
4
Latest round
Series c
Latest round date
Apr 2021
Latest amount
120,000,000 USD
Investors
12
Lead investors
4
Listing status
private

Corporate family

Acquisitions made
1

About this record

Sources
Crunchbase, LinkedIn
Last imported
Sept 2026

Growth, as the source summarises it

CeQur Simplicity may be growing as it has recently obtained FDA clearance for its wearable mealtime insulin delivery device, which now allows for 4 days of wear. This regulatory milestone can enhance the company's product offering and potentially increase its market share in the medical device industry. The FDA clearance is a significant achievement that typically leads to increased product credibility and can facilitate a rise in sales and revenue.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

Medical Device in Switzerland.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 36,795 companies in Switzerland and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.